Cargando…

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection

Due to the relation between lipids and Hepatitis C virus (HCV) life-cycle, we aimed to explore the existence of single nucleotide polymorphisms (SNPs) associated with low susceptibility to HCV-infection within lipid metabolism genes. This was a case-control study in three phases: (I) allelic frequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Real, Luis Miguel, Macías, Juan, Rivero-Juárez, Antonio, Téllez, Francisco, Merino, Dolores, Moreno-Grau, Sonia, Orellana, Adelina, Gómez-Salgado, Juan, Sáez, María E., Frías, Mario, Corma-Gómez, Anaïs, Merchante, Nicolás, Ruiz, Agustín, Caruz, Antonio, Pineda, Juan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588564/ https://www.ncbi.nlm.nih.gov/pubmed/31227787 http://dx.doi.org/10.1038/s41598-019-45389-4

Ejemplares similares

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
por: Núñez-Torres, Rocío, et al.
Publicado: (2016)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
por: Merchante, Nicolás, et al.
Publicado: (2015)

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure
por: Corma-Gómez, Anaïs, et al.
Publicado: (2021)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV
por: Rivero-Juárez, Antonio, et al.
Publicado: (2013)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals
por: Rivero-Juárez, Antonio, et al.
Publicado: (2020)

IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians
por: Real, Luis M., et al.
Publicado: (2014)

Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
por: Corma-Gómez, Anaïs, et al.
Publicado: (2022)

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
por: Real, Luis M., et al.
Publicado: (2018)

Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR
por: Frías, Mario, et al.
Publicado: (2019)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2014)

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
por: Santos, Marta, et al.
Publicado: (2023)

CD46 Genetic Variability and HIV-1 Infection Susceptibility
por: Serrano-Rísquez, Carmen, et al.
Publicado: (2021)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2014)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
por: Brochado-Kith, Óscar, et al.
Publicado: (2019)

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014
por: Neukam, Karin, et al.
Publicado: (2016)

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
por: Macias, Juan, et al.
Publicado: (2022)

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort
por: Neukam, Karin, et al.
Publicado: (2016)

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2016)

Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection
por: Rivero-Juarez, Antonio, et al.
Publicado: (2021)

No association of a risk variant for severe COVID-19 with HIV protection in three cohorts of highly exposed individuals
por: Sironi, Manuela, et al.
Publicado: (2022)

Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection
por: Merchante, Nicolás, et al.
Publicado: (2021)

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
por: Macías, Juan, et al.
Publicado: (2021)

Optimization of the molecular diagnosis of the acute hepatitis E virus infection
por: Lopez‐Lopez, Pedro, et al.
Publicado: (2023)

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis
por: Cuypers, Lize, et al.
Publicado: (2018)

Temporal changes in the genotypes of Paslahepevirus balayani in southern Spain and their possible link with changes in pig trade imports
por: Lopez-Lopez, Pedro, et al.
Publicado: (2023)

Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure
por: Frias, Mario, et al.
Publicado: (2018)

Hepatitis E Infection in HIV-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2019)

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
por: von Massow, Georg, et al.
Publicado: (2019)

Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy
por: Frias, Mario, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dmahdesd1ts1v8k4fijh5g18ql